|
1
|
van Staa TP, Leufkens HG, Abenhaim L,
Begaud S, Zhang B and Cooper C: Use of oral corticosteroids in the
United Kingdom. QJM. 93:105–111. 2000.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fardet L, Petersen I and Nazareth I:
Prevalence of long-term oral glucocorticoid prescriptions in the UK
over the past 20 years. Rheumatology (Oxford). 50:1982–1990.
2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Overman RA, Yeh JY and Deal CL: Prevalence
of oral glucocorticoid usage in the United States: A general
population perspective. Arthritis Care Res (Hoboken). 65:294–298.
2013.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Silverman S, Curtis J, Saag K, Flahive J,
Adachi J, Anderson F, Chapurlat R, Cooper C, Diez-Perez A,
Greenspan S, et al: International management of bone health in
glucocorticoidexposed individuals in the observational GLOW study.
Osteoporos Int. 26:419–420. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Ventura A, Brunetti G, Colucci S, Oranger
A, Ladisa F, Cavallo L, Grano M and Faienza MF:
Glucocorticoid-induced osteoporosis in children with 21-hydroxylase
deficiency. Biomed Res Int. 2013(250462)2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Delany AM, Dong Y and Canalis E:
Mechanisms of glucocorticoid action in bone cells. J Cell Biochem.
56:295–302. 1994.PubMed/NCBI View Article : Google Scholar
|
|
7
|
O'Brien CA, Jia D, Plotkin LI, Bellido T,
Powers CC, Stewart SA, Manolagas SC and Weinstein RS:
Glucocorticoids act directly on osteoblasts and osteocytes to
induce their apoptosis and reduce bone formation and strength.
Endocrinology. 145:1835–1841. 2004.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Stamatopoulos B, Meuleman N, Haibe-Kains
B, Saussoy P, Van Den Eric N, Michaux L, Heimann P, Martiat P, Bron
D and Lagneaux L: microRNA-29c and microRNA-223 down-regulation has
in vivo significance in chronic lymphocytic leukemia and improves
disease risk stratification. Blood. 113:5237–5245. 2009.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lee ST, Chu K, Im WS, Yoon HJ, Im JY, Park
JE, Park KH, Jung KH, Lee SK, Kim M and Roh JK: Altered microRNA
regulation in huntington's disease models. Exp Neurol. 227:172–179.
2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Du JK, Cong BH, Yu Q, Wang H, Wang L, Wang
CN, Tang XL, Lu JQ, Zhu XY and Ni X: Upregulation of microRNA-22
contributes to myocardial ischemia-reperfusion injury by
interfering with the mitochondrial function. Free Radic Biol Med.
96:406–417. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shi C, Qi J, Huang P, Jiang M, Zhou Q,
Zhou H, Kang H, Qian N, Yang Q, Guo L and Deng L: MicroRNA-17/20a
inhibits glucocorticoid-induced osteoclast differentiation and
function through targeting RANKL expression in osteoblast cells.
Bone. 68:67–75. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Y, Gao Y, Cai L, Li F, Lou Y, Xu N,
Kang Y and Yang H: MicroRNA-221 is involved in the regulation of
osteoporosis through regulates RUNX2 protein expression and
osteoblast differentiation. Am J Transl Res. 9:126–135.
2017.PubMed/NCBI
|
|
13
|
Liang WC, Fu WM, Wang YB, Sun YX, Xu LL,
Wong CW, Chan KM, Li G, Waye MM and Zhang JF: H19 activates Wnt
signaling and promotes osteoblast differentiation by functioning as
a competing endogenous RNA. Sci Rep. 6(20121)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang RB, Lin FF, Yang J, Chen B, Zhang MH,
Lu QP, Xiao B, Liu Y, Zheng K and Qiu YR: Overexpression of CAV3
facilitates bone formation via the Wnt signaling pathway in
osteoporotic rats. Endocrine. 63:639–650. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Chen F, Zhang L, OuYang Y, Guan H, Liu Q
and Ni B: Glucocorticoid induced osteoblast apoptosis by increasing
E4BP4 expression via up-regulation of Bim. Calcif Tissue Int.
94:640–647. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zhang L, Yin HL, Jiao L, Liu TY, Gao YQ,
Shao YC, Zhang YY, Shan HL, Zhang Y and Yang BF: Abnormal
downregulation of caveolin-3 mediates the pro-fibrotic action of
MicroRNA-22 in a model of myocardial infarction. Cell Physiol
Biochem. 45:1641–1653. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Galbiati F, Engelman JA, Volonte D, Zhang
XL, Minetti C, Li M, Hou H Jr, Kneitz B, Edelmann W and Lisanti MP:
Caveolin-3 null mice show a loss of caveolae, changes in the
microdomain distribution of the dystrophin-glycoprotein complex,
and t-tubule abnormalities. J Biol Chem. 276:21425–21433.
2001.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gohel A, McCarthy MB and Gronowicz G:
Estrogen prevents glucocorticoid-induced apoptosis in osteoblasts
in vivo and in vitro. Endocrinology. 140:5339–5347. 1999.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Carotenuto F, Minieri M, Monego G,
Fiaccavento R, Bertoni A, Sinigaglia F, Vecchini A, Carosella L and
Di Nardo P: A diet supplemented with ALA-rich flaxseed prevents
cardiomyocyte apoptosis by regulating caveolin-3 expression.
Cardiovasc Res. 100:422–431. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou Q, Peng X, Liu X, Chen L, Xiong Q,
Shen Y, Xie J, Xu Z, Huang L, Hu J, et al: FAT10 attenuates
hypoxia-induced cardiomyocyte apoptosis by stabilizing caveolin-3.
J Mol Cell Cardiol. 116:115–124. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Tang YH, Yue ZS, Li GS, Zeng LR, Xin DW,
Hu ZQ and Xu CD: Effect of β-ecdysterone on glucocorticoid-induced
apoptosis and autophagy in osteoblasts. Mol Med Rep. 17:158–164.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bowers GN Jr and McComb RB: A continuous
spectrophotometric method for measuring the activity of serum
alkaline phosphatase. Clin Chem. 12:70–89. 1966.PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Meng SS, Wang H, Xue DB and Zhang WH:
Screening and validation of differentially expressed extracellular
miRNAs in acute pancreatitis. Mol Med Rep. 16:6412–6418.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Sun F, Yang X, Jin Y, Chen L, Wang L, Shi
M, Zhan C, Shi Y and Wang Q: Bioinformatics analyses of the
differences between lung adenocarcinoma and squamous cell carcinoma
using the cancer genome atlas expression data. Mol Med Rep.
16:609–616. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lin J, Huo R, Xiao L, Zhu X, Xie J, Sun S,
He Y, Zhang J, Sun Y, Zhou Z, et al: A novel p53/microRNA-22/Cyr61
axis in synovial cells regulates inflammation in rheumatoid
arthritis. Arthritis Rheumatol. 66:49–59. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vurusaner B, Poli G and Basaga H: Tumor
suppressor genes and ROS: Complex networks of interactions. Free
Radic Biol Med. 52:7–18. 2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Li H, Xie H, Liu W, Hu R, Huang B, Tan YF,
Xu K, Sheng ZF, Zhou HD, Wu XP and Luo XH: A novel microRNA
targeting HDAC5 regulates osteoblast differentiation in mice and
contributes to primary osteoporosis in humans. J Clin Invest.
119:3666–3677. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Li Z, Zhang W and Huang Y: MiRNA-133a is
involved in the regulation of postmenopausal osteoporosis through
promoting osteoclast differentiation. Acta Biochim Biophys Sin
(Shanghai). 50:273–280. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Guo DW, Han YX, Cong L, Liang D and Tu GJ:
Resveratrol prevents osteoporosis in ovariectomized rats by
regulating microRNA-338-3p. Mol Med Rep. 12:2098–2106.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Christodoulou F, Raible F, Tomer R,
Simakov O, Trachana K, Klaus S, Snyman H, Hannon GJ, Bork P and
Arendt D: Ancient animal microRNAs and the evolution of tissue
identity. Nature. 463:1084–1088. 2010.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li H, Qian W, Weng X, Wu Z, Li H, Zhuang
Q, Feng B and Bian Y: Glucocorticoid receptor and sequential P53
activation by dexamethasone mediates apoptosis and cell cycle
arrest of osteoblastic MC3T3-E1 cells. PLoS One.
7(e37030)2012.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Crochemore C, Michaelidis TM, Fischer D,
Loeffler JP and Almeida OF: Enhancement of p53 activity and
inhibition of neural cell proliferation by glucocorticoid receptor
activation. FASEB J. 16:761–770. 2002.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Tang Z, Scherer PE, Okamoto T, Song K, Chu
C, Kohtz DS, Nishimoto I, Lodish HF and Lisanti MP: Molecular
cloning of caveolin-3, a novel member of the caveolin gene family
expressed predominantly in muscle. J Biol Chem. 271:2255–2261.
1996.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chen Z, Qi Y and Gao C: Cardiac
myocyte-protective effect of microRNA-22 during ischemia and
reperfusion through disrupting the caveolin-3/eNOS signaling. Int J
Clin Exp Pathol. 8:4614–4626. 2015.PubMed/NCBI
|
